Viatris Inc. share price logo

Viatris Inc. Share Price

NASDAQ: VTRS

Large Cap

$10.02

-0.09

(-0.89%)

Live

as on

Viatris Inc. Stock Performance

as on November 8, 2025 at 1:38 am IST

  • Day's Low

    Day's High

    $9.92
    $10.16
    downward going graph

    1.00%

    Downside

    1.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $6.85
    $13.55
    downward going graph

    31.64%

    Downside

    35.23%

    Upside

    downward going graph

Viatris Inc. share price movements today

Previous Close
$10.11
Open
$10.09
Volume
6.7M
Day's Low - High
$9.92 - $10.16
52 Week Low - High
$6.85 - $13.55

Viatris Inc. Historical Returns

1 Month Return
-0.3 %
3 Month Return
+ 7.67 %
1 Year Return
-23.29 %
3 Year Return
-7.84 %
5 Year Return
0 %

Viatris Inc. Stock Fundamentals & Key Indicators

Check Viatris Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.4B

EPS (TTM)

2.2859

Dividend Yield

3.95%

Quarterly Earnings Growth YOY

-0.71%

PE Ratio (TTM)

-21.95

Industry PE ratio

19.200384615384614

PEG Ratio

0.1436

EBITDA

4.1B

Revenue (TTM)

14.1B

Profit Margin

-24.57%

Return On Equity TTM

-19.77%

Viatris Inc. Stock Valuation

Track how Viatris Inc. P/E has moved over time to understand its valuation trends.

Viatris Inc. in the last 5 years

  • Overview

  • Trends

Lowest (2.83x)

September 30, 2022

Today (-21.95x)

November 7, 2025

Industry (19.20x)

November 7, 2025

Highest (5.86x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: -21.95x

Viatris Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Viatris Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Viatris Inc. image
Viatris Inc.
HOLD$12.4BNA-21.95-24.57%
United Therapeutics Corporation image
United Therapeutics Corporation
BUY$19.5BNA17.2140.65%
Haleon Plc Spon Ads image
Haleon Plc Spon Ads
BUY$41.9BNA21.6513.81%
Neurocrine Biosciences Inc. image
Neurocrine Biosciences Inc.
BUY$15.3B60.68%36.6915.95%
Zoetis Inc. image
Zoetis Inc.
BUY$53.4B-29.36%20.7727.83%

Stock Returns calculator for Viatris Inc. Stock including INR - Dollar returns

The Viatris Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Viatris Inc. investment value today

Current value as on today

₹81,131

Returns

₹18,869

(-18.87%)

Returns from Viatris Inc. Stock

₹23,976 (-23.98%)

Dollar Returns*

₹5,107 (+5.11%)

Analyst Recommendation on Viatris Inc. Stock

Based on 14 analysts

HOLD

7.14%

Buy

57.14%

Hold

35.71%

Sell

Based on 14 analysts, 57.14% of analysts recommend a 'HOLD' rating for Viatris Inc.. Average target price of $12

Viatris Inc. Share Price Target

Get share price movements and forecasts by analysts on Viatris Inc..

What analysts predicted

16.5%UPSIDE

Target Price

$12

Current Price

$10.02

Analyzed by

14 Analysts

Target

$12.00

Viatris Inc. target price $12, a slight upside of 16.5% compared to current price of $10.02. According to 14 analysts rating.

Viatris Inc. Stock’s Investor Sentiment and Interest

Search interest for Viatris Inc. Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-15% versus previous 30 day period

Viatris Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
3,729
3,918
3,941
3,837
3,663
3,796
3,751
3,528
3,254
3,582
Gross Profit
1,542
1,608
1,691
1,596
1,504
1,445
1,459
1,215
1,161
1,332
Operating Income
399
369
451
-454
203
-239
225
-179
-2,882
233
EBITDA
1,199
1,163
1,223
-69
1,034
540
905
339
-2,316
577
Interest Expense
147
143
141
140
138
145
145
120
115
116
Depreciation
730
686
679
644
691
786
669
746
664
678
Income Before Tax
322
333
402
-855
204
-391
90
-526
-3,097
-217
Income Tax Expense
98
69
70
-89
90
-65
-4
-10
-55
-212
Net Income
224
264
331
-765
113
-326
94
-516
-3,042
-4
Net Profit Margin
6.03%
6.74%
8.41%
-19.95%
3.11%
-8.60%
2.53%
-14.64%
-93.48%
-0.13%

Viatris Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
9,429
11,076
11,907
11,433
11,500
11,946
17,886
16,262
15,426
14,739
Gross Profit
4,216
4,697
4,783
4,001
3,897
3,796
5,575
6,497
6,438
5,623
Operating Income
1,460
699
1,437
905
715
-210
-34
1,614
766
10
EBITDA
2,286
2,099
3,243
2,950
2,691
1,992
4,478
6,433
3,516
2,820
Interest Expense
336
454
534
542
517
497
636
592
573
550
Depreciation
-
-
1,805
2,109
2,019
2,216
4,506
3,027
2,965
2,893
Income Before Tax
915
121
903
298
154
-721
-664
2,813
202
-623
Income Tax Expense
67
358
207
54
137
-51
604
734
148
11
Net Income
847
480
696
352
16
-669
-1,269
2,078
54
-634
Net Profit Margin
8.99%
4.33%
5.84%
3.08%
0.15%
-5.61%
-7.10%
12.78%
0.35%
-4.30%

Viatris Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
264
331
-765
113
-326
94
-516
-3,042
-4
Operating Cash Flow
514
834
479
614
379
826
482
535
219
Investing Cash Flow
-76
-53
115
-154
375
1,747
-168
-65
-52
Financing Cash Flow
-303
-97
-926
-425
-847
-1,636
-1,420
-467
-362
Change in Cash
120
680
-318
22
-97
961
-1,144
20
-188

Viatris Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
480
696
352
20
-669
-1,269
2,078
54
-634
Operating Cash Flow
2,047
2,064
2,341
1,803
1,231
3,016
2,952
2,799
2,302
Investing Cash Flow
-7,677
-976
-1,210
-525
-301
-117
1,520
-764
1,800
Financing Cash Flow
5,344
-1,893
-1,090
-1,169
-605
-3,012
-3,877
-2,301
-4,330
Change in Cash
-89
-777
19
101
358
-143
556
-268
-257

Mutual Funds that own Viatris Inc. Stock

Check out the Mutual Funds with significant holdings in Viatris Inc..

Global Institutional Holdings in Viatris Inc.

Funds
Holdings
Vanguard Group Inc
12.45%
BlackRock Inc
7.11%
T. Rowe Price Associates, Inc.
6.76%
Davis Selected Advisers
5.69%
State Street Corp
4.74%
See all

Viatris Inc. News & Key Events

  • img

    Today's Timeline - 06 November

    Thu, 08:54 PM

    -

    Viatris reports Q3 2025 adjusted EPS of $0.67, beating estimates, with total revenues of $3.76 billion.

Insights on Viatris Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 3.25B → 3.58B (in $), with an average increase of 9.2% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -3.04B → -4.6M (in $), with an average increase of 66030.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 27.9% return, outperforming this stock by 35.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Neurocrine Biosciences Inc. has given 24.9% return, outperforming this stock by 48.2%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, VTRS stock has moved down by -0.3%

About Viatris Inc.

mylan is a global pharmaceutical company committed to setting new standards in healthcare. working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. we offer a growing portfolio of around 1,400 generic pharmaceuticals and several brand medications. in addition, we offer a wide range of antiretroviral therapies, upon which nearly 50% of hiv/aids patients in developing countries depend. we also operate one of the largest active pharmaceutical ingredient manufacturers and currently market products in about 145 countries and territories. our workforce of approximately 30,000 people is dedicated to creating better health for a better world, one person at a time. learn more at mylan.com.
OrganisationViatris Inc.
HeadquartersRobert J. Coury Global Center, Canonsburg, PA, United States, 15317
IndustryHealth Technology
CEOMr. Scott Andrew Smith Ph.D.
E-voting on sharesClick here to vote

Key Management of Viatris Inc.

Name

Title

Mr. Paul B. Campbell

Chief Accounting Officer & Corporate Controller

Mr. Brian S. Roman

Chief Legal Officer

Mr. Philippe Martin

Chief R&D Officer

Mr. Peter McCormick

Chief Supply Officer

Ms. Lara Ramsburg

Chief Corporate Affairs Officer

Mr. Scott Andrew Smith Ph.D.

CEO & Director

Ms. Theodora Mistras

Chief Financial Officer

Dr. Corinne M. Le Goff M.B.A., Pharm.D.

Chief Commercial Officer

Mr. Ramkumar V. Rayapureddy

Chief Information Officer

Mr. Andrew Enrietti

Chief Administrative & Transformation Officer

FAQs

What is Viatris Inc. share price today?

Viatris Inc. share price today is $10.02 as on . Viatris Inc. share today touched a day high of $10.16 and a low of $9.92.

What is the 52 week high and 52 week low for Viatris Inc. share?

Viatris Inc. share touched a 52 week high of $13.55 on and a 52 week low of $6.85 on . Viatris Inc. stock price today i.e. is trending at $10.02,which is 26.05% down from its 52 week high and 46.28% up from its 52 week low.

What is Viatris Inc.'s market capitalisation today?

Viatris Inc. market capitalisation is $0.01T as on .

How to invest in Viatris Inc. Stock (VTRS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Viatris Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Viatris Inc. Shares that will get you 0.1497 shares as per Viatris Inc. share price of $10.02 per share as on November 8, 2025 at 1:38 am IST.

What is the minimum amount required to buy Viatris Inc. Stock (VTRS) from India?

Indian investors can start investing in Viatris Inc. (VTRS) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Viatris Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Viatris Inc. share’s latest price of $10.02 as on November 8, 2025 at 1:38 am IST, you will get 0.9980 shares of Viatris Inc.. Learn more about fractional shares .